Genistein: Clinical Trials

46 trials of Genistein, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29 completed, 5 terminated, 4 unknown, 3 not yet recruiting. 29 Phase 2, 17 Phase 1, 10 Not applicable, 4 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 229Completed 16, Terminated 5, Unknown 3, Not yet recruiting 2, Withdrawn 2, Recruiting 1
Phase 117Completed 9, Not yet recruiting 2, Unknown 2, Withdrawn 2, Recruiting 1, Terminated 1
Not applicable10Completed 8, Not yet recruiting 1, Recruiting 1
Phase 34Completed 4
Early Phase 11Completed 1
Phase 41Unknown 1

Follow Genistein: new trials by email Literature Review of Genistein trials Research Report on Genistein

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Genistein for the Reduction of Adverse Cardiovascular Events (GRACE)
Genistein (Unconjugated Isoflavones 100), Placebo - HIV, Vascular Disease
Phase 1 / Phase 2Not yet recruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's602026-09-302026-08-25
Effectiveness of Genistein in Mild Cognitive Impairment
Genistein, Control product placebo - Alzheimer Disease (AD), Mild Cognitive Impairment (MCI)
Not applicableNot yet recruitingUniversidad Católica San Antonio de Murcia1502026-02-012026-02-17
Evaluating Metabolic and Anti-inflammatory Effect of Genistein on Post-myocardial Infarction Patients
genistein - Myocardial Infarction (MI)
Not applicableRecruitingNational Taiwan University Hospital732025-09-012025-08-07
Exploring a Natural Solution for Childhood Obesity
genistein - Obesity, Children
Phase 1 / Phase 2Not yet recruitingWestern University302025-08-012025-06-24
Genistein, Equol, Cognitive Function and Mood: Acute. (GECFAMa)
Genistein, Equol, Maltodextrin (Placebo) - Cognition, Mood
Not applicableCompletedUniversity of Reading532024-11-142026-08-07
Genistein, Equol, Cognitive Function and Mood: Twelve-week. (GECFAMc)
Equol, Genistein, Maltodextrin - Cognition, Mood
Not applicableCompletedUniversity of Reading512024-11-012026-08-03
The Clinical Study on Isoflavone Genistein in Restructuring the Gut Microbiota of Hyperlipidemia Patients
Genistein - Hyperlipidemia
Not applicableCompletedShenzhen Hospital of Southern Medical University362024-10-132025-03-26
Genistein in trAnSthyretin recePtor Amyloid caRdiomyopathy
Genistein - Amyloid Cardiomyopathy
Phase 1 / Phase 2RecruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's202024-09-272025-06-15
Cardiovascular Genistein Therapy for Heart Failure Inflammation
Genistein - Heart Failure
Phase 1 / Phase 2UnknownUniversity Medical Centre Ljubljana402024-07-012024-07-15
BIO 300 Oral Powder Safety and Pharmacokinetics
BIO 300 Oral Powder - Acute Radiation Syndrome
Phase 1CompletedHumanetics Corporation342020-12-082024-05-03
Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate Cancer
Genistein, Placebo - Prostate Cancer
Phase 2TerminatedEmory University102017-10-162022-09-27
Genistein as a Possible Treatment for Alzheimer's Disease.
Genistein, Placebo - Alzheimer's Disease
Not applicableCompletedFundación para la Investigación del Hospital Clínico de Valencia272017-09-012021-09-10
Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment
Genistein, Sugar pill - Bladder Cancer
Phase 2CompletedEmory University362017-05-192025-02-05
Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)
Genistein, Placebo - Lymphoma, Childhood Lymphoma
Phase 2TerminatedUniversity of Virginia42016-08-012024-05-06
BIO 300 Non-Small Cell Lung Cancer Study
BIO 300 Oral Suspension, Paclitaxel, Carboplatin - Carcinoma, Non-Small-Cell Lung
Phase 1 / Phase 2CompletedHumanetics Corporation212015-11-012024-01-25
Phase I/II a Study of Decitabine in Combination With Genistein in Pediatric Relapsed or Refractory Malignancies
Decitabine and Genistein - Cancer
Phase 1 / Phase 2CompletedSt. Justine's Hospital62015-07-012017-11-17
Effect of Enteral Genistein Supplementation in Sepsis
Genistein, enteral nutrition only - Sepsis
Phase 4UnknownTC Erciyes University302015-06-012016-06-13
Isoflavone Treatment for Postmenopausal Osteopenia.
Red clover extract, Supplementation (placebo) - Osteopenia, Osteoporosis
Not applicableCompletedUniversity of Aarhus852014-06-012023-12-04
Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck
Soy isoflavone, Radiation, Cisplatin - Cancer of Head and Neck
Phase 1CompletedEmory University242013-11-012019-12-06
Genistein in Treatment of Metastatic Colorectal Cancer
Genistein - Colon Cancer, Rectal Cancer
Phase 1 / Phase 2CompletedSofya Pintova132013-11-012019-05-10

Showing 20 of 46. Sign in to see all of them.

Conditions studied

Prostatic Neoplasms (8)  ·  Breast Neoplasms (4)  ·  Osteoporosis (4)  ·  Carcinoma, Non-Small-Cell Lung (3)  ·  Inflammation (3)  ·  Metabolic Syndrome (3)  ·  Neoplasms (3)  ·  Pancreatic Neoplasms (3)  ·  Alzheimer Disease (2)  ·  Bone Diseases, Metabolic (2)  ·  Carcinoma, Renal Cell (2)  ·  Cardiovascular Diseases (2)  ·  Cystic Fibrosis (2)  ·  Glucose Intolerance (2)  ·  Kidney Neoplasms (2)

Sponsors

National Cancer Institute (NCI) (4)  ·  Emory University (3)  ·  Northwestern University (3)  ·  University of Messina (3)  ·  Barbara Ann Karmanos Cancer Institute (2)  ·  Children's Hospital of Philadelphia (2)  ·  Humanetics Corporation (2)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (2)  ·  UNC Lineberger Comprehensive Cancer Center (2)  ·  University of Reading (2)  ·  Axcentua Pharmaceuticals AB (1)  ·  Creighton University (1)  ·  Fundación para la Investigación del Hospital Clínico de Valencia (1)  ·  Imperial College London (1)  ·  Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1)

Countries

United States (21)  ·  Canada (4)  ·  United Kingdom (3)  ·  China (2)  ·  Italy (2)  ·  Spain (2)  ·  Denmark (1)  ·  Norway (1)  ·  Slovenia (1)  ·  Sweden (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)

Top investigators

Francesco Squadrito, MD (3)  ·  Claire Williams, PhD (2)  ·  Daniel Lamport, PhD (2)  ·  Luke R Till, MSc (2)  ·  Mark JK Chandy, MD PhD (2)  ·  Ronald Rubenstein, M.D., PhD. (2)  ·  Amy Weise, DO (1)  ·  Bato Lazarevic, MD (1)  ·  David Jarrard (1)  ·  Donna Kritz-Silverstein (1)  ·  Edward Garon, MD (1)  ·  Fazlul H. Sarkar, PhD (1)  ·  Henrique Bittencourt, MD (1)  ·  Howard H Bailey (1)  ·  J C Gallagher (1)

Results publications

PMID 33331662, PMID 37983082, PMID 17577003, PMID 18446090, PMID 22293631, PMID 22307566, PMID 23899172, PMID 28489488, PMID 28768651, PMID 31203390, PMID 36301689, PMID 36329553

NIH funding

N01CN35153 (2), P30CA022453 (2), N01CN35157 (1), P30CA014520 (1), P30CA138292 (1), P50CA090386 (1), R01HL057790 (1)